Mr. Chair, earlier I asked the minister a question about the Canadian diabetes strategy. I could have asked him the same question about the prostate cancer strategy.
Am I right in understanding that senior officials at Health Canada are asking the minister to no longer reserve funds for particular illnesses, and that it would be a mistake not to reserve funds specifically for diabetes or prostate cancer?
Can the minister assure us that there will still be funding set aside for certain, very carefully identified pathologies?